E-DRUG: Virtual workshop on Oct. 27: Fighting falsified and substandard
medicines during the COVID-19 crisis
---------------------------------------------------------------------------
Dear e-druggers,
please note the following virtual workshop, to be held on Oct. 27, 2020,
CET: 11:00 AM - 12:30 PM / UTC: 10:00 AM - 11:30 AM:
WS 17 - Fighting falsified and substandard medicines during the COVID-19
crisis:
Increased demand and interrupted supply chains offer opportunities for
counterfeiters
Digital Participation is possible free of charge and without
registration via:
https://worldhealthsummit-org.zoom.us/j/95786548029
Further information: https://www.conference.worldhealthsummit.org/
Hosts: Association of Research-based Pharmaceutical Companies (vfa);
German Federal Ministry for Economic Affairs and Energy (BMWi)
Chair: Prof. Dr. Lutz Heide, Pharmaceutical Institute, Eberhard Karls
University Tuebingen; Germany
Speakers:
- Dr. Moji Christianah Adeyeye, Director-General, National Agency for
Food & Drug Administration and Control (NAFDAC), Nigeria
- Dr. Richard Neci, Executive Director, Ecumenical Pharmaceutical
Network (EPN), Kenya
- Prof. Dr. Pierre Claver Kayumba, Senior Lecturer and Researcher,
- Dr. Karim Bendhaou, Head of Africa Bureau, Merck, Germany
- Prof. Dr. Sachiko Ozawa, Eshelman School of Pharmacy, University of
North Carolina, USA
Summary: The fight against falsified and substandard medicines in low-
and middle-income countries (LMICs) is a major challenge. With
constrained access to essential medicines, weak technical capacity for
medicine quality assurance and control, and challenges in appropriate
governance both in health care facilities and in national medicines
regulatory authorities, many LMICs show the conditions which WHO has
identified as favouring the occurrence of substandard and falsified
medicines.
Additionally, the COVID-19 crisis led to a disruption of the
production and supply chains of medicines worldwide, and some countries
stopped the export of medicines.
Newly developed medicines and vaccines against COVID-19 will be in very high demand. All this creates increased opportunities for the distribution of falsified medicines by criminals.
In this session we will try to assess the situation from the viewpoints
of different stakeholders, and discuss possible strategies to counteract
the proliferation of falsified medicines, with a focus on Africa.
There will be a Questions & Answers session after the speaker
presentations, in which also remote participant can contribute questions.
Best wishes
Prof. Dr. Lutz Heide
Pharmazeutisches Institut, Universita Tubingen
Kaiserdamm 87
14057 Berlin
Prof. Dr. Lutz Heide
e-mail heide@uni-tuebingen.de